Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2021 1
2022 4
2023 7
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Trastuzumab Plus Gemcitabine-Cisplatin for Treatment-Naïve Human Epidermal Growth Factor Receptor 2-Positive Biliary Tract Adenocarcinoma: A Multicenter, Open-Label, Phase II Study (TAB).
Ostwal V, Mandavkar S, Bhargava P, Srinivas S, Kapoor A, Shetty O, Kannan S, Chaugule D, Patil R, Parulekar M, Nashikkar C, Ankathi SK, Baheti AD, Mehta D, Kaushal RK, Yadav S, Shah A, Patkar S, Goel M, Ramaswamy A. Ostwal V, et al. Among authors: kaushal rk. J Clin Oncol. 2024 Mar 1;42(7):800-807. doi: 10.1200/JCO.23.01193. Epub 2023 Nov 9. J Clin Oncol. 2024. PMID: 37944079 Clinical Trial.
Safety, toxicity and pharmacokinetic assessment of oral Withaferin-A in mice.
Gupta SK, Jadhav S, Gohil D, Panigrahi GC, Kaushal RK, Gandhi K, Patil A, Chavan P, Gota V. Gupta SK, et al. Among authors: kaushal rk. Toxicol Rep. 2022 May 18;9:1204-1212. doi: 10.1016/j.toxrep.2022.05.012. eCollection 2022. Toxicol Rep. 2022. PMID: 36518386 Free PMC article.
Withaferin-A alleviates acute graft versus host disease without compromising graft versus leukemia effect.
Kumar Gupta S, Gohil D, Dutta D, Panigrahi GC, Gupta P, Dalvi K, Khanka T, Yadav S, Kumar Kaushal R, Chichra A, Punatar S, Gokarn A, Mirgh S, Jindal N, Nayak L, Tembhare PR, Khizer Hasan S, Kumar Sandur S, Hingorani L, Khattry N, Gota V. Kumar Gupta S, et al. Among authors: kumar kaushal r. Int Immunopharmacol. 2023 Aug;121:110437. doi: 10.1016/j.intimp.2023.110437. Epub 2023 Jun 11. Int Immunopharmacol. 2023. PMID: 37311352
Epidemiological Trend of Esophageal Cancer at a Tertiary Cancer Center in Mumbai, India, Over the Past 15 Years.
Noronha V, Sekar A, Rajendra A, Mokal S, Patil V, Menon N, Chopade S, Singh AK, Kaushal RK, Mahajan A, Janu A, Purandare N, Dikshit R, Banavali S, Prabhash K, Badwe R. Noronha V, et al. Among authors: kaushal rk. J Gastrointest Cancer. 2023 Sep;54(3):903-912. doi: 10.1007/s12029-022-00887-z. Epub 2022 Nov 23. J Gastrointest Cancer. 2023. PMID: 36418768
Deep learning based automated epidermal growth factor receptor and anaplastic lymphoma kinase status prediction of brain metastasis in non-small cell lung cancer.
Mahajan A, B G, Wadhwa S, Agarwal U, Baid U, Talbar S, Janu AK, Patil V, Noronha V, Mummudi N, Tibdewal A, Agarwal JP, Yadav S, Kumar Kaushal R, Puranik A, Purandare N, Prabhash K. Mahajan A, et al. Among authors: kumar kaushal r. Explor Target Antitumor Ther. 2023;4(4):657-668. doi: 10.37349/etat.2023.00158. Epub 2023 Aug 30. Explor Target Antitumor Ther. 2023. PMID: 37745691 Free PMC article.
13 results